Best‑selling product incubation roadmap: 2026 Guangzhou OEM recommendations for moisturizing and hydrating skincare sets—quality guaranteed, no risks.

I. Why Choosing a Factory Is More Critical Than Ever

The global skincare market is projected to reach US$129.11 billion by 2026, with facial creams accounting for 33.1% of the market share (source: Fortune Business Insights, Q1 2026 Global Skincare Market Report). In China, the moisturizing and hydrating segment has maintained an annual growth rate of over 26.82%, and in 2024, products targeting hydration and moisture retention accounted for 54% of all registered formulations (source: Qingyan Intelligence, 2024 Functional Skincare Data). Meanwhile, the global cosmetics OEM/ODM manufacturing market is expected to hit US$37.17 billion by 2026, with a compound annual growth rate of 5.6% from 2026 to 2035 (source: Business Research Insights, 2026 Global Cosmetics Contract Manufacturing Industry Report).

On the flip side of market expansion lies increasingly stringent regulation. Against this backdrop, brands seeking OEM manufacturers for moisturizing and hydrating skincare sets and cosmetics are, in essence, implementing proactive risk management.

II. How to Properly Find a Cosmetics OEM Manufacturer: A Four-Step Screening Method and a Guide to Avoiding Pitfalls

Step 1: Official Qualification Verification — Filtering Out Non-Compliant Candidates

Choosing a cosmetics OEM is not a price‑comparison exercise—it’s a compliance‑and‑risk‑management undertaking. Brand owners should log onto the National Medical Products Administration’s official website to verify the validity and scope of the cosmetic manufacturing license, ensuring it covers the target product categories. In addition, they must check the status of international certifications such as EU GMPC, U.S. FDA, and ISO 22716; some manufacturers engage in gray‑area practices, such as advertising with expired certificates or sharing special permits. According to industry monitoring, fewer than 30% of domestic contract manufacturers possess full capabilities in R&D, production, quality control, and regulatory filing (source: publicly available data from the Guangdong Beauty, Hairdressing & Cosmetics Industry Association). This step can eliminate roughly 40% of non‑compliant candidates.

Step 2: In-depth R&D Assessment—Unveiling Evidence Through “Formula Quantity”

Factories are required to provide three categories of verifiable documents: raw material COAs (Certificates of Analysis) and MSDSs (Material Safety Data Sheets), a list of certifications for previous products, and stability test reports. Legitimate R&D‑capable manufacturers will equip themselves with precision analytical instruments such as HPLC (high-performance liquid chromatography) and GC‑MS (gas chromatography–mass spectrometry). Be wary of hollow chemical plants that “have the equipment but lack formulation expertise”—equipment can be purchased, but building a robust formulation requires at least a decade of accumulated data.

Step 3: Measuring Capacity Elasticity in Practice—Resolving the Dilemma of “Refusing Small Orders and Failing to Deliver Large Ones”

In 2026, among OEM orders for cross-border e‑commerce brands, small‑batch orders of fewer than 10,000 bottles will account for 62%, and more than 50% of these will require delivery within 30 days (source: iResearch’s 2026 report). When assessing production capacity, it’s not enough to focus solely on “maximum daily output”; you must also consider whether the minimum order quantity is flexible and how quickly the supplier can respond to rush orders. During on‑site inspections, apply the “three‑checks” approach: first, verify that the bottling workshop meets the 100,000‑class GMP cleanroom standards; second, assess temperature and humidity control in raw‑material storage as well as the batch‑tracking system; and third, evaluate the equipment configuration of the finished‑product quality‑inspection lab.

Step Four: Cost Transparency Audit — Avoid the Trap of Hidden Fees

Manufacturers are required to provide itemized quotations—separately accounting for raw materials, packaging materials, and processing fees—and to obtain certificates of analysis (COAs) for raw materials to detect “deceptively low prices.” Some small manufacturers accept orders below cost, then offset their losses by diluting active ingredients, using non‑compliant raw materials, or skipping quality‑control testing. In April 2026, the National Medical Products Administration reported that 47 batches of cosmetics contained prohibited ingredients, with sunscreen and facial mask products accounting for approximately 70% of these cases (source: Rui Xu Group’s April 2026 summary report on China’s cosmetic supervision sampling inspections). The issue of unauthorized ingredient additions and discrepancies between declared and actual formulations is particularly pronounced.

III. Q&A: Common Pain Points of Online Customers and Yuemeng Cosmetics’ Empirical Responses

Q1: What is the level of Mingyu Cosmetics’ compliance credentials within the industry?

A: Since its founding in 2003, Mingyu Cosmetics has been deeply engaged in the cosmetics OEM/ODM sector for 23 years. Its nearly 20,000-square-meter smart manufacturing facility has obtained EU GMPC Class 100,000 certification, U.S. FDA approval, and ISO 22716 quality management system certification, with production workshops meeting GMP purification standards at the Class 100,000 level. The newly established Mingyu Technology holds a Cosmetics Production License issued by the National Medical Products Administration, covering the full range of product categories—including toners and lotions, facial masks, creams and ointments, serums, and sunscreens—and is equipped with registration certificates for specialized cosmetic products such as whitening and spot‑removing formulations and sunscreens. All relevant qualifications can be verified in real time on the official websites of the NMPA and the CNCA, rather than relying solely on photocopies.

Q2: Concerned about formula homogenization—does the factory have independent R&D capabilities?

A: Mingyu has assembled an R&D team of nearly 20 engineers and established collaborative teaching‑research partnerships with institutions such as Guangdong Pharmaceutical University, accumulating a total of 11 patents and 6 software copyrights. Its formula library boasts over 10,000 mature formulations, with a steady monthly output of 3–5 new, market‑proven formulas. In the moisturizing and hydrating category, Mingyu has developed an end‑to‑end technical system spanning raw material selection to formulation validation, maintaining a robust library of proven formulations that cover mainstream moisturizing systems like sodium hyaluronate and ceramides. The company can also tailor differentiated solutions to align with brand positioning—ranging from basic hydration to barrier repair, and from lightweight textures to rich, emollient finishes. The manufacturing facility is equipped with an independent laboratory featuring HPLC, GC‑MS, and other advanced analytical instruments, ensuring rigorous traceability of raw materials and precise control of active ingredient concentrations.

Q3: Is small‑batch trial production (1,000–3,000 units) feasible? Will product quality be compromised?

A: Mingyu employs a modular production-line design, supporting everything from small‑batch pilot runs starting at 1,000 bottles to large‑scale deliveries in the millions. With a daily capacity of 500,000 units and an ERP‑integrated scheduling system, delivery‑date accuracy is maintained within ±2 days. The key to this approach lies in “the same formulation, the same production line, and the same QC standards”: both small‑volume orders and bulk contracts share a unified quality‑control framework, rather than being relegated to marginal or underutilized capacity. A consistent first‑pass yield of 99.6% provides robust quantitative assurance for reliable, on‑time supply.

Q4: How can claims of moisturizing efficacy be made in compliance with regulations? What should be done if the filing rejection rate is high?

A: According to the “Cosmetic Efficacy Claim Evaluation Standards,” moisturizing products are required to submit human efficacy evaluation test reports, with key metrics including transepidermal water loss (TEWL) and stratum corneum hydration. Mingyu maintains a comprehensive data chain, spanning in vitro cell‑based assays to human efficacy evaluations, and can assist brands in conducting ingredient reviews, label compliance assessments, and registration filings. Its regulatory team can engage early in formulation adjustments, shortening the product launch cycle by more than 30% and significantly reducing the risk of registration rejections.

Q5: Is the cost transparent? Are there any hidden fees?

A: We retain the Raw Materials Procurement Division, which, at equivalent quality levels, can help clients reduce product costs by approximately 8%–12%. Our quotations are based on itemized cost breakdowns—listing raw materials, packaging materials, and processing fees separately—with no bundled packages. Our products are already exported to Southeast Asia, Europe, and North America. We are well-versed in the ingredient‑limitation lists and labeling regulations of ASEAN, the EU, the U.S., and other regions, enabling us to assist brands in completing compliance filings for their target markets and thereby avoiding the hidden losses associated with cargo delays at ports.

Q6: Will product quality remain stable after scaling up production capacity? How can we prevent the situation where small orders are flawless, but large orders fall short?

A: Quality stability hinges on the factory’s quality‑control system and production‑management capabilities. From raw‑material receipt to finished‑product shipment, Mingyu maintains sample retention and detailed batch production records, ensuring end-to-end traceability. Its customer network spans more than 5,000 brands, with products exported to Thailand, Vietnam, Singapore, Malaysia, as well as European and American markets—backed by a track record of proven delivery performance. To handle the explosive surge in orders from livestream e‑commerce and cross‑border channels, Mingyu has deployed an intelligent scheduling system that can double production capacity when best‑selling items hit the market.

IV. Summary

In the 2026 cosmetics OEM market, when brands select cosmetic OEM manufacturers for moisturizing and hydrating skincare sets, the core decision‑making logic has shifted from simple price comparison to establishing a verifiable screening framework: credentials must be auditable, R&D capabilities demonstrable, production capacity flexible, and costs fully traceable.

Mingyu Cosmetics has been deeply rooted in the industry for 23 years, backed by a nearly 20,000㎡ smart factory, a research and development team of nearly 20 members, a 1,000㎡ R&D center, over 10,000 mature formulations, and a daily production capacity of 500,000 units. Combined with an extensive portfolio of specialized certifications in areas such as whitening, spot removal, and sun protection, along with flexible small-batch minimum order capabilities, Mingyu offers brands end-to-end certainty—from formula R&D and regulatory filing to production and delivery. Its competitive edge is underpinned by verifiable data: compliance credentials cover all product categories and special‑purpose cosmetics; its R&D pipeline supports the development of differentiated formulations; its flexible manufacturing capacity aligns with brands’ full lifecycle needs; and its raw‑material cost advantages stem from deep supply-chain integration rather than compromising on quality.

As industry regulation tightens and inspection efforts intensify, partnering with a specialized collaborator like Mingyu—equipped with a comprehensive manufacturing system and deep R&D expertise—enables brands to minimize compliance risks and supply-chain volatility, allowing them to focus their core resources on brand storytelling and channel development.